Qepler | summits & conferences | 2nd Annual Drug/Device Combination Products Summit, 4-5 December 2019
Event Location:
Prague, Czech Republic
Novotel Praha Wenceslas Square Hotel Katerinska 1476/38
04 December 2019 - 05 December 2019

Conference Overview

Drug/device combination products represent the next wave of drug delivery devices of increasing complexity. Their development requires the number of technical challenges to consider - integrating drug and device systems, defining the elements of design control, determining quality systems and manufacturing processes. It is also critical to establish a regulatory and clinical strategy from early on in development. Our meeting facilitates a better understanding of both regulatory and practical aspects of developing drug-device combinations, as well as the management of combination products across the total product life cycle.

The featured talks on:

  • Preparing for EU MDR implementation and its implications on combination products.
  • Registering DDC products across the globe. LCM strategies and regulatory considerations.
  • Platform selecting and engaging the right stakeholders in the product development process.
  • Addressing the differences and gaps between drug and device development plans.
  • Streamlining a quality management system to support sustainable LCM.
  • Identifying essential performance requirements and associated control strategies.
  • Integration of design control throughout LCM. Design verification and process validation.
  • Risk-based approaches to design and development of drug delivery systems.
  • Utilizing human factors in combination products risk management.
  • How to compile a clinical evaluation for combination products.
  • Drug/device compatibility, safety evaluation and testing for combination products.
  • Best practices for post approval changes. Understanding when a change is a change.
  • Assessing post market surveillance to support effective lifecycle management.
  • Driving innovations to extend your combination product lifespan.
  • Connected digital technologies and next generation combination products.

Meet our Speakers

Our Sponsors

Speaker Sponsor
Intertek (Schweiz) AG



▸AbbVie ▸Ablynx ▸anteris medical ▸AOP Orphan Pharmaceuticals ▸Astellas Pharma ▸AstraZeneca ▸BIOCORP ▸Biogen ▸Boehringer Ingelheim microParts ▸Bristol-Myers Squibb ▸BSI Group ▸Corvus Device ▸Cytel ▸Design Science ▸Eli Lilly ▸Freelancer ▸GSK ▸H&B Electronic ▸H&T Presspart ▸Hanway Associates ▸Janssen ▸LEO Pharma ▸Maetrics ▸Medac ▸Medtronic ▸Nelson Labs ▸Nelson Labs Europe ▸Novartis ▸Orion Corporation - Orion Pharma ▸Pall Life Sciences ▸Pharmathen ▸Progress-PME ▸Regeneron Pharmaceuticals ▸Sanofi R&D ▸Sanofi-Aventis ▸sfm medical devices ▸Sharp Clinical Services ▸Spiegelberg ▸TERUMO EUROPE ▸tesa Labtec ▸Teva ▸UPM Raflatac


Serge Mathonet

Sanofi R&D

chaired a panel discussion with speakers from TERUMO EUROPE, Novartis, anteris medical GmbH, GlaxoSmithKline, AstraZeneca and Corvus Device.

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.